BVF as of Dec. 31, 2023
Portfolio Holdings for BVF
BVF holds 70 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Moonlake Immunotherapeutics Class A Ord (MLTX) | 32.9 | $1.3B | 22M | 60.39 | |
Revolution Medicines (RVMD) | 4.3 | $172M | 6.0M | 28.68 | |
Axsome Therapeutics (AXSM) | 3.9 | $158M | 2.0M | 79.59 | |
Protagonist Therapeutics (PTGX) | 3.3 | $132M | 5.7M | 22.93 | |
Kymera Therapeutics (KYMR) | 3.3 | $131M | 5.2M | 25.46 | |
Mirum Pharmaceuticals (MIRM) | 3.2 | $129M | 4.4M | 29.52 | |
Olema Pharmaceuticals (OLMA) | 3.2 | $128M | 9.1M | 14.03 | |
Ionis Pharmaceuticals (IONS) | 3.1 | $123M | 2.4M | 50.59 | |
Kura Oncology (KURA) | 2.7 | $106M | 7.4M | 14.38 | |
4d Molecular Therapeutics In (FDMT) | 2.0 | $81M | 4.0M | 20.26 | |
Galapagos Nv Spon Adr (GLPG) | 1.9 | $78M | 1.9M | 40.65 | |
Merus N V (MRUS) | 1.9 | $76M | 2.8M | 27.50 | |
Repare Therapeutics Ord (RPTX) | 1.9 | $75M | 10M | 7.30 | |
Ac Immune Sa SHS (ACIU) | 1.8 | $73M | 15M | 5.00 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.7 | $70M | 8.8M | 7.96 | |
Xoma Corp Del Com New (XOMA) | 1.7 | $67M | 3.6M | 18.50 | |
Ideaya Biosciences (IDYA) | 1.5 | $62M | 1.7M | 35.58 | |
Zymeworks Del (ZYME) | 1.5 | $61M | 5.9M | 10.39 | |
Gh Research Ordinary Shares (GHRS) | 1.5 | $60M | 10M | 5.80 | |
Essa Pharma Com New (EPIX) | 1.4 | $58M | 8.7M | 6.60 | |
Janux Therapeutics (JANX) | 1.2 | $49M | 4.6M | 10.73 | |
Third Harmonic Bio (THRD) | 1.2 | $48M | 4.4M | 10.97 | |
89bio (ETNB) | 1.1 | $45M | 4.0M | 11.17 | |
Relay Therapeutics (RLAY) | 1.1 | $44M | 4.0M | 11.01 | |
Xenon Pharmaceuticals (XENE) | 1.0 | $41M | 890k | 46.06 | |
Syndax Pharmaceuticals (SNDX) | 1.0 | $41M | 1.9M | 21.61 | |
Tyra Biosciences (TYRA) | 0.9 | $38M | 2.7M | 13.85 | |
Lexicon Pharmaceuticals Com New (LXRX) | 0.9 | $37M | 24M | 1.53 | |
Structure Therapeutics Sponsored Ads (GPCR) | 0.8 | $33M | 813k | 40.76 | |
Cullinan Oncology (CGEM) | 0.8 | $33M | 3.2M | 10.19 | |
An2 Therapeutics (ANTX) | 0.8 | $32M | 1.6M | 20.49 | |
Annexon (ANNX) | 0.8 | $32M | 7.0M | 4.54 | |
Roivant Sciences SHS (ROIV) | 0.8 | $31M | 2.7M | 11.23 | |
Silence Therapeutics Ads (SLN) | 0.7 | $26M | 1.5M | 17.37 | |
Allakos (ALLK) | 0.6 | $23M | 8.6M | 2.73 | |
Glycomimetics (GLYC) | 0.6 | $23M | 9.5M | 2.36 | |
Ovid Therapeutics (OVID) | 0.6 | $22M | 6.9M | 3.22 | |
Engene Holdings (ENGN) | 0.5 | $21M | 2.3M | 9.23 | |
Calliditas Therapeutics Ab Sponsered Ads (CALT) | 0.5 | $19M | 750k | 25.77 | |
Tscan Therapeutics (TCRX) | 0.4 | $17M | 3.0M | 5.83 | |
Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.4 | $17M | 1.5M | 11.17 | |
Spyre Therapeutics Com New (SYRE) | 0.4 | $15M | 687k | 21.52 | |
Sutro Biopharma (STRO) | 0.4 | $14M | 3.3M | 4.29 | |
Iteos Therapeutics (ITOS) | 0.3 | $14M | 1.3M | 10.95 | |
Verastem Com New (VSTM) | 0.3 | $14M | 1.7M | 8.14 | |
Immunovant (IMVT) | 0.3 | $13M | 300k | 42.13 | |
Vistagen Therapeutics Ord (VTGN) | 0.3 | $10M | 2.0M | 5.14 | |
Cytomx Therapeutics (CTMX) | 0.3 | $10M | 6.6M | 1.55 | |
Ikena Oncology (IKNA) | 0.2 | $9.4M | 4.8M | 1.97 | |
Verve Therapeutics (VERV) | 0.2 | $9.1M | 650k | 13.94 | |
Eledon Pharmaceuticals (ELDN) | 0.2 | $7.8M | 4.3M | 1.80 | |
SAB Biotherapeutics | 0.2 | $6.3M | 9.2M | 0.69 | |
Vigil Neuroscience (VIGL) | 0.2 | $6.1M | 1.8M | 3.38 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.1 | $5.4M | 6.9M | 0.79 | |
Rain Therapeutics | 0.1 | $4.2M | 3.5M | 1.20 | |
Delcath Sys Com New (DCTH) | 0.1 | $4.1M | 976k | 4.16 | |
Pieris Pharmaceuticals (PIRS) | 0.1 | $3.8M | 21M | 0.18 | |
Kronos Bio (KRON) | 0.1 | $3.6M | 2.9M | 1.25 | |
Nls Pharmaceutics SHS (NLSP) | 0.1 | $3.4M | 5.7M | 0.59 | |
Inventiva Sa Ads (IVA) | 0.1 | $3.1M | 686k | 4.48 | |
Forte Biosciences (FBRX) | 0.1 | $2.5M | 3.0M | 0.82 | |
Corvus Pharmaceuticals (CRVS) | 0.1 | $2.4M | 1.4M | 1.76 | |
Viracta Therapeutics (VIRX) | 0.1 | $2.1M | 3.6M | 0.57 | |
Molecular Templates Com New (MTEM) | 0.0 | $2.0M | 532k | 3.70 | |
Unicycive Therapeutics (UNCY) | 0.0 | $1.8M | 2.1M | 0.87 | |
Molecular Partners Ads (MOLN) | 0.0 | $1.8M | 443k | 3.98 | |
Elevation Oncology (ELEV) | 0.0 | $1.2M | 2.3M | 0.54 | |
Engene Holdings *w Exp 10/31/202 (ENGNW) | 0.0 | $804k | 945k | 0.85 | |
Aslan Pharmaceuticals Spon Ads New (ASLN) | 0.0 | $548k | 1.0M | 0.52 | |
Rezolute Com New (RZLT) | 0.0 | $189k | 191k | 0.99 |